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Abstract
In this paper we test the 'red herring' hypothesis for expenditures on
long-term care. The main contribution of this paper is that we assess
the 'red herring' hypothesis using an aggregated measure that allows us
to control for entering the ﬁnal period of life on the individual level. In
addition we implement a model that allows for age speciﬁc time-to-death
(TTD) eﬀects on Long Term Care. We also account for the problem that
mortality, and therefore TTD, are themselves inﬂuenced by care expen-
diture. For our analysis we use administrative data from the Swedish
statistical oﬃce.
In contrast to many previous empirical studies, we are able to use the
entire population for estimation instead of a sample. Our identiﬁcation
strategy is based on ﬁxed eﬀects estimation and the instrumental variable
approach to achieve exogenous variation in TTD. Our results indicate
that although time-to-death is a relevant indicator for long term care, age
itself seems to be much more important for the projection of long-term
care expenditure.
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1 Introduction
Most developed countries' populations are ageing rapidly with consequent impli-
cations for public spending on long-term care (LTC), pensions and health care.
The Swedish dependency ratio (the number of retired people per 100 people of
working age) is projected to increase from 28 today to 40 in 2050.
Such demographic changes are expected to have a signiﬁcant impact on the
demand for care services. Most consumers of LTC are over age 80; for example,
in Sweden, almost 80 per cent of care home inhabitants belong to this age group
(SALAR 2009). Since increasing life expectancy implies this group is growing
faster than the general retired population, there is concern that the demographic
burden could make the current system of ﬁnancing LTC unsustainable. Indeed,
in many countries there has been a trend towards concentrating resources only
on individuals with severe disability (Karlsson et al. 2004). Even if there is no
silver bullet how to deal with this problem, modern societies and policy makers
need to know how many resources are needed due to the changes in the demand
for care services. Therefore, a precise projection of the impact of ageing on care
services is necessary. An often discussed issue is whether there is the problem
of an omitted variable. If the period of intense care needs is simply postponed
when life expectancy increases, age itself has limited explanatory power once
time-to-death (TTD) of older people is also taken into account. Empirical stu-
dies controlling for this variable are marred with several issues. In addition to
the problem of omitted variables, one problem that has not been solved to sa-
tisfaction is the possibility of simultaneity the fact that supply of care services
may also aﬀect TTD, and hence bias the estimates. The current study has three
main aims: Firstly, we use a new and innovative TTD-measure to estimate its
impact on institutional and domiciliary LTC-costs with aggregated administra-
tive data, which is publicly available. In comparison with existing research on
the 'red herring' hypothesis that uses population sub-samples with individual
data, this approach has the advantage that the ﬁndings are representative for
the whole population. Secondly, we test to what extent costs occurring with
TTD vary between diﬀerent age groups. Thirdly, we attempt to address the en-
dogeneity problem associated with TTD. Our identiﬁcation strategy is twofold:
As a ﬁrst step, we implement the ﬁxed eﬀects estimator to allow for unobser-
ved heterogeneity and in a second step, we instrument the TTD variable, using
diﬀerent sources of regional speciﬁc variation in mortality.
This paper is organised as follows: In the next section, we review the eco-
nomic literature on the relationship between ageing, morbidity and care expen-
diture. In the third section, we present the data-set and discuss our empirical
strategy. Then our results are presented, which are used to quantify budget
eﬀects of a 1 year increase in life expectancy. The ﬁnal section summarises our
ﬁndings and their implications for policy.
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2 Health and Population Ageing
There is a related literature stream in economics, which analyses the implications
of population ageing for health care costs. Much attention has been devoted to
the so-called 'red herring' hypothesis, according to which care costs are unrelated
to age once remaining lifetime has been controlled for. In a seminal paper,
Zweifel et al. (1999) used individual-level Swiss data to investigate this issue.
They show that the impact of age on health care costs decreases once `time-
to-death' (TTD) is taken into account. During the last two years of life, an
individual's actual age seems to be completely irrelevant. This leads to their
conclusion that age is not necessarily an important determinant of health care
expenditures.
Subsequent studies by Salas and Raftery (2001) and Seshamani and Gray
(2004) criticise the approach of Zweifel et al. on several grounds. First, they
claim that there might be a problem of collinearity of the explanatory variables,
which makes it impossible to disentangle the contribution of diﬀerent expla-
natory factors. Second, there is possibly reverse causation running from care
expenditures to TTD, which would lead to endogeneity bias. Using a similar
data-set and a similar approach to Zweifel et al. but including additional va-
riables, Seshamani and Gray (2004) conclude that while morbidity is highly
relevant for health care costs, age also remains important.
Zweifel et al. (2004) address these issues. They use past health care expendi-
tures as instrumental variables for current expenditures and they estimate their
model in two steps to avoid potential collinearity problems. Nevertheless, they
conclude that in most age groups, TTD is more important than age. In a related
study, Stearns and Norton (2004) use an American panel data-set. They ﬁnd
both age and TTD to be statistically signiﬁcant, but the impact of TTD much
larger. Werblow et al. (2007) focus on LTC and use panel data from Switzerland.
They decompose the eﬀect for diﬀerent categories of care and show that most
components of health care expenditure are driven, not by age, but by TTD. An
exception is expenditures on acute care for long-term patients for which TTD
comes out insigniﬁcantly.
In a related study from the US, Shang and Goldman (2008) ﬁnd that age has
limited predictive power once remaining individual life expectancy is introduced
into the model. Similarly, Weaver et al. (2009) use panel data from the US and
focus mainly on LTC costs since they account for the bulk of care costs for
older people. They implement a simultaneous equations probit model to address
joint decisions of demand for LTC and cohabitation with an adult child. Their
ﬁndings suggest that TTD is the main cost driver, but being married reduces
its importance.
Using a Dutch data-set on home care utilisation, de Meijer et al. (2009)
diﬀerentiate between diﬀerent causes of death and analyse the impact of mor-
bidity. Once morbidity and disability are controlled for, the age eﬀect remains
relevant, whereas TTD becomes insigniﬁcant. They conclude that TTD cannot
causally aﬀect care expenditures and might itself be seen as a red herring: it
is simply a proxy for morbidity and disability. In a recent study, Felder et al.
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(2010) address the reverse causality problem by using instrumental variables for
TTD. Their ﬁndings suggest that the increase in health care expenditures is
much more likely caused by a shift of medical technology than by ageing of the
population  so TTD seems to matter.
The argument that TTD is a proxy for morbidity (cf. de Meijer et al, 2009)
can be challenged with reference to Gerstorf et al. (2010). In their study, the
decline in well-being prior to death is being investigated. Using individual-level
data from Germany, the UK the US, they estimate separate well-being curves
for each country. Their ﬁndings suggest that there is a signiﬁcant kink in the
well-being curve in the last few years of life. The use of diﬀerent data sources
allows comparing this phase of decline in diﬀerent populations, and it appears
to vary between 3 and 5 years.
There is also evidence on the 'red-herring' hypothesis using aggregated data; e.g.
Bech et al. (2010) focus on the relation of population demographics, mortality,
life expectancy and health expenditure costs for the the EU-15 countries, using
mortality rates to control health care expenditures. They suggest that rather
past than present values, of life expectancy and mortality rates, are predictors
of health care expenditures. They explain this phenomenon via a delay of policy
budget decisions.
We are aware of some other studies, which formally test the 'red herring'
hypothesis for Sweden. Batljan and Lagergren (2000) ﬁnd the ratios for Swedish
elderly people who need help, as well as the ones who receive help, declining over
time. They suggest that ageing is not the main determinant of care services. In
another study Batljan and Lagergren (2004) analyse Swedish individual level
data of one county. They focus on both in and outpatient health care during
the period from 1992-1997, and use the data to disentangle age and mortality
related costs. Based on oﬃcial Swedish mortality and population projections up
to 2030, they then compare 2 scenarios for the development of health care costs.
They show that the increase of health care costs will be about 37 percent lower
when mortality is accounted for than a simple demographical extrapolation
would suggest. A study by Karlsson and Klohn (2011) use the same data source
than this study. Simple mortality rates are used to measure the impact of TTD
on expenditures on social care for the overall population. Compared this study
their model does not account for age speciﬁc TTD-eﬀects and the problem of
reverse causation. Their ﬁndings suggest ageing to be the main predictor of
Swedish social care expenditures.
In a recent study, Larsson, Kåreholt and Thorslund (2008) evaluate the
eﬀect of age and TTD on care for older people in Sweden. The emphasis is
on utilization of home help services, institutional care and hospital care. They
conclude that TTD has twice the impact of actual age  thus giving support for
the 'red herring' hypothesis. Other studies that address the age proﬁle of care
costs in Sweden have been conducted by e.g. Gerdtham (1993), Thorslund and
Parker (1995), Gerdtham, Lundin and Sáez-Martí (2005).
Although the theoretical concept of TTD seems to be quite intuitive, the
academic debate about its meaning/interpretation is controverse and the empi-
rical implementation diﬀers between the mentioned studies. First, this variable
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should not be seen as continuous, as its name suggests, since morbidity is not a
linear combination of an individual's age. Second, in practice TTD should rat-
her be seen as controlling for morbidity, being related to the time period before
dying, in which individuals are in need of external help and care.
In conclusion, the jury is still out on the red herring hypothesis, and there
is clearly a need for more studies which corroborate previous ﬁndings with more
sophisticated methods.
3 Empirical Strategy
In this paper, we analyse the impact of population ageing on the expenditures
on social care services using adminstrative data from Swedish authorities. In
particular, we contrast a simple demographic model for explaining social care
expenditure with models that allow for compression of morbidity by assuming
that old-age morbidity is a function not only of age, but also of TTD.
In Sweden, social care policies are the responsibility of municipalities, of
which there are 290 in total. Directly elected politicians decide on the supply
of services and also raise the revenues necessary to cover operating costs. Local
income taxes are the main source of funding, and out-of-pocket payments are of
limited importance (3.7 per cent of total costs, as of 2007; SALAR, 2009). The
national government lays down general principles and responsibilities for social
care in law and monitors the quality in care homes. Furthermore, it redistributes
funds to create equal opportunities for the provision of LTC in all parts of the
country despite immense diﬀerences in need as well as in the local tax bases.
Even though the market share of private providers has tripled over the last
two decades (e.g. from 5.4 to 13.7 per cent for nursing home slots; cf. Socials-
tyrelsen, 2002, 2008) virtually all formal social care provided in Sweden is still
funded and monitored by local authorities, which keep meticulous records of the
amounts, types and costs of care services provided. These data are collected by
the National Board for Health and Welfare, which ensures that they are com-
parable between municipalities and over time. Thus, the possibilities to conduct
analysis of the impact of demographic changes on demand for social care are
excellent, as we have access to high-quality data aggregated on the regional level
that cover the entire population of a country. This is a huge advantage compared
to most previous research on the 'red herring' hypothesis..
3.1 Dataset
To implement the concept of TTD in our model, we consider contemporary and
future mortality rates of the 65+ population. In our framework, we assume a
high mortality rate of the 65+ individuals being related to a high care level and
therefore, also positively related to long-term care expenditures. The following
period's mortality rate should be related to a higher quantity of long-term care
as well, since these individuals are also assumed to have a high probability of
being in contemporary need for external support. Our main variable of interest
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is average local costs of social care, deﬁned as the sum of institutional and home
care expenditures for older people. Standardised information is available for the
time range 1998-2008. For demographic data, we use oﬃcial records provided
by Statistics Sweden. These data-sets include the number of residents in each
age cohort and for each municipality. Also, mortality rates are available for each
local authority. Our main units of observation are the 290 municipalities. In our
Tabelle 1: Summary statistics
Variable Descrition Mean Std. Dev.
Total Total care costs per 65+ inhabitant in kSEK 57.376 9.002
Inst Institutional care costs per 65+ inhabitant in kSEK 36.749 7.890
Dom Domiciliary care costs per 65+ inhabitant in kSEK 18.146 5.619
age6569 People aged 65-69 divided by population 65+ 0.265 0.032
age7074 People aged 70-74 divided by population 65+ 0.233 0.015
age7579 People aged 75-79 divided by population 65+ 0.209 0.016
age8084 People aged 80-84 divided by population 65+ 0.159 0.017
age8589 People aged 85-89 divided by population 65+ 0.091 0.013
age9094 People aged 90-94 divided by population 65+ 0.035 0.007
age95100 People aged 95-100+ divided by population 65+ 0.008 0.003
mrt Deaths (65+) divided by the elderly population 0.051 0.007
mrtL1 Next period's mrt for population at t-1 0.053 0.007
TTD65+ Aggregate of mrt and mrtL1 0.102 0.011
TTD6569 TTD for population 6569 0.007 0.002
TTD7074 TTD for popultion 7074 0.011 0.003
TTD7579 TTD for population 7579 0.017 0.004
TTD8084 TTD for population 8084 0.023 0.004
TTD8589 TTD for population 8589 0.024 0.004
TTD9094 TTD for population 9094 0.014 0.003
TTD95100+ TTD for population 95100+ 0.005 0.002
medinc65_08 Median income of 65+ population 153.652 19.414
wom65 Share of women of 65+ population 0.555 0.019
density Population density 126.722 416.08
rightwing Share of the right-winged parties seats 0.345 0.097
TTD2554 TTD of 25-54 aged people in each municipality 0.003 0.001
absmrtdiﬀ Absolute value of diﬀerence between dying men 0.019 0.011
and women divided by population (80+)
analysis we focus on the subpopulation of inhabitants aged 65+, since only this
group is eligible for LTC. Our main regressand is therefore overall care costs
divided by the average population that is 65 years or older, but we also provide
regressions separately for institutional and domiciliary care costs. Using the
average 65+ population per year as the denominator for our care expenditure
variables, we avoid the problem that the contemporary mortality rate in our
TTD variable is controlling for a decreasing demand for care services.
One innovation of the methodology used in this study is that we model the
TTD variable in a way that allows to control for TTD eﬀects that arise on
the individual level in a reasonable way. For this purpose we deﬁne the TTD
variables in our study as
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TTDait = (1− (1−mrt
a
it)× (1−mrt
a+1
i,t+1))×
Nait
N
65+
it
which can be interpreted as the probability to die within 2 years for people in
speciﬁc age group. The mortality rates mrt are calculated as the number of older
people in a speciﬁc age group a deceased within a year, divided by the number
of people (Nait) in age group a alive at the beginning of the respective period.
Mortality rates shall capture aggregate TTD in a municipality. For example,
the current-year mortality rate corresponds to all individuals in age group a
who had less than one year left to live at the beginning of the year. The next
year's mortality rate is calculated with respect to age group a, i.e. we use the
aggregated mortality for a speciﬁc contemporary age group, accounting for the
fact that population age shifts by 1 year, from year to year. In our baseline
model a is simply the 65+ population but group speciﬁc TTD variables (e.g.
TTD6569it is the aggregated mortality for the 65 to 69 year old people) are also
used in our analysis.
Other main explanatory variables are those capturing the age structure amongst
the old in each municipality. These variables are deﬁned as the number of older
people, measured in intervals of ﬁve years, divided by the number of people aged
65+. Again, these variables are measured at the beginning of each year.
Since all variables are expressed in terms of averages per 65+ inhabitant, all
estimated parameters correspond exactly to their individual-level equivalents.
To account for inﬂation, we standardised all costs according to the Swedish
producer price index: they are expressed in 2008 crowns. As can be seen in Ta-
ble 11, the average costs for overall care are around 57,400 SEK (6,400 Euro)
per capita, but they range between 23,500 and 94,400 SEK. The aggregates of
contemporary and next period's mortality rate range between 0.03 and 0.09.
Turning to the variables representing the age structure, we see that they follow
the expected pattern: the shares decrease rapidly at advanced ages. Other varia-
bles used for robustness checks are the median income of the people aged 65+
(kSEK), the centre-right parties share of all seats in the town hall, population
density and the share of women in the 65+ population.
In our IV estimates, we introduce two further variables, which we believe
to be suitable instruments for TTD. Firstly, we use the absolute value of the
diﬀerence between the mortality of women and men, being 80 years and older,
divided by the total population of this age group. Secondly, we use the aggregate
of this year's and next year's mortality rate of the middle aged population (25-
55 years) as an instrumental variable. We will discuss the rationale behind our
approach and the assumptions made in more detail below.
3.2 Fixed Eﬀects Estimation
We assume a ﬂexible relationship between our explanatory variables (age groups
and aggregated mortality rate of the elderly) and the dependent variable (care
1More detailed in Appendix A1
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costs per 65+ population). If there are region-speciﬁc confounders which cor-
relate with the demographics and our dependent variable, a Random Eﬀects
estimate based on this model will be biased. Even though the age structure can
be seen as exogenous, this will possibly not be the case with TTD, which may
be correlated with many unobserved characteristics of the municipalities. This
would lead to biased estimates of the impact of TTD, thus also inﬂuence the
estimated the age eﬀects. A Hausman test strongly supports this hypothesis, so
that the consistency of the Randon Eﬀects model can be rejected. We therefo-
re rely on the Fixed Eﬀects estimator, assuming that possible confounders are
constant over time. We also control for factors that might have changed over
time, but are assumed to be constant for all regions in our analysis, e.g. changes
of life expectancy due to pharmaceutical innovations (Schnittker, Karandinos,
2010). Therefore, we include time dummies in our model.
In separate analysis, we provide estimates with other covariates included to
evaluate the robustness of our ﬁndings. Furthermore, we estimate the impact of
age and TTD on care costs, allowing for age speciﬁc TTD-eﬀects in our model.
To account for heteroskedasticity in our model, all estimates use weighted least
squares. The weights reﬂect the inverse relation between the variance of the
outcome variable and the size of the population.
3.3 Instrumenting time-to-death
Although we assume that the ﬁxed eﬀects estimator already reduces potential
bias due to the problem of reverse causality  the fact that expenditure on
care for older people might inﬂuence TTD  we also use 2 stage least squares
in a separate analysis. We need to ﬁnd a good instrument that is on the one
hand relevant (i.e., has a signiﬁcant impact on TTD) and on the other hand
randomly assigned. Using aggregated mortality of older people as a measure
for their morbidity makes it natural to take advantage of other demographic
information related to the population's morbidity.
One instrumental variable we use is the absolute value of the diﬀerence
between the mortality of men and women, being 80 years and older, divided by
the total population in this age group:
|M80+women−M
80+
men|
N80+
With this variable we want to account for eﬀects of marriage (e.g. Gardner,
Oswald, 2004) and social relationships (e.g. Cohen, Janicki-Deverts, 2009) on
individual health. The intuition behind this variable is that if one person in a
relationship dies, this might have direct inﬂuence on the living partner`s health,
either directly or via a decreasing social interaction to other people. Although
we are not able to compare a couple's morbidity and mortality on the individual
level with our data, we hope that our instrumental variable allows to control for
such a mechanism on an aggregated level. To exclude the possibility of endoge-
neity of this IV, we have to assume that LTC expenditures do not inﬂuence the
morbidity of women and men diﬀerently.
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If standard assumptions are satisﬁed, there still is the concern about our
IV estimates that it is diﬃcult to tell whether the subpopulation aﬀected is
representative. We would like to assume that the impact of TTD on expected
care costs is the same for the entire older population, but this is not necessarily
the case, especially since our IV is just deﬁned for the 80+ population. Thus,
we would like to check whether the impact of TTD is the same irrespective of
the exogenous variation used for identiﬁcation. For this reason, we consider a
second instrumental variable which is based on the mortality rates of the middle
aged population (25 to 54 years old):
TTD2554it = 1− (1−mrt
a=25,..,54
it )× (1−mrt
a+1
i,t+1)
It cannot have an impact on LTC because this group is by law not eligible to
use elderly LTC services. We aggregate both the contemporary and next year's
mortality rates to have an instrumental variable that is in parallel deﬁned to
the endogeneous variable TTD. We assume our IV not to have a direct inﬂuence
on the endogeneous variable, but it is assumed to account for regional speciﬁc
mortality that is varying over time. This assumption is ﬁrstly, just reasonable if
the mortality is correlated between the middle aged and elderly people, which
is testable in the ﬁrst stage of our 2SLS estimation. Secondly, we not have to
necessarily assume that our variable is itself related to functional impairments
of the younger population, but we have to assume that it is correlated with
morbidity amongst older people in the population. Müller-Nordhorn et al. (2008)
are investigating cardiovascular mortality in Europe. Classifying countries into
high- and low risk categories, they ﬁnd several diseases also varying on the
regional level. The reasons for this are manifold and in principle one can imagine
that every factor that is inﬂuencing population health, and is varying regionally,
can potentially lead to a heterogeneous morbidity outcome in diﬀerent regions.
Given that the mechanisms linking both instrumental variables to care needs
and TTD are quite diﬀerent, we assume them to be an ideal combination for
our purposes.
4 Results
4.1 Fixed Eﬀects Estimates
In Table 2, the results of our Fixed Eﬀects speciﬁcations are displayed. The ﬁrst
column shows the coeﬃcients of a regression of overall care costs per capita on
the population shares of older people. In the following 2 columns, we successively
introduce contemporary and next period's mortality rate respectively to see if
the age group coeﬃcients are aﬀected  which would be an indication of a red
herring problem. The 4th, 5th and 6th column allow a comparison between
overall, institutional and domiciliary care costs.
Focusing ﬁrst on the analysis for overall care costs, the coeﬃcients for most
age groups are positive and signiﬁcant, except for the ones aged 70 to 74, which
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turn out to be insigniﬁcant. This suggests that age related costs are not a big
issue in these younger cohorts.
In the column excluding the mortality rate, FE (1), the coeﬃcient for 80
to 84 year old people indicates that an individual in this age group incurs an
increase of total care costs of 35,800 SEK (¿ 4,000) per year (in addition to the
average for an individual aged 65 to 69, captured by the constant).
Table 2: LTC
(1) (2) (3) (4) (5) (6)
Total Total Total Total Inst Dom
age7074 -6.95 -7.46 -8.54 -8.55 16.60 -18.35
(15.12) (15.08) (14.99) (14.99) (16.97) (13.83)
age7579 7.49 6.45 4.26 4.22 -5.83 9.41
(15.36) (15.40) (15.30) (15.30) (19.87) (15.81)
age8084 35.80** 34.09* 30.26* 30.24* 15.05 22.25
(17.70) (17.88) (17.84) (17.85) (19.81) (14.87)
age8589 129.43*** 126.08*** 120.34*** 120.03*** 56.15** 57.18***
(19.59) (20.01) (20.26) (20.24) (22.15) (18.75)
age9094 226.06*** 220.41*** 209.74*** 209.35*** 75.21* 132.97***
(29.30) (29.83) (29.73) (29.66) (40.49) (32.02)
age95100 287.98*** 280.23*** 271.39*** 270.00*** 138.14 152.52**
(59.74) (60.43) (60.40) (60.21) (83.87) (69.40)
mrt 21.52 25.56
(14.96) (15.69)
mrtL1 37.80**
(14.89)
TTD65+ 34.11** 49.08*** -13.36
(14.10) (16.08) (13.07)
Constant 26.95*** 26.95*** 26.91*** 26.82*** 18.65* 4.50
(9.04) (9.03) (9.00) (9.00) (10.60) (8.35)
Observations 3009 3009 3009 3009 3009 3009
R2 0.593 0.594 0.595 0.595 0.275 0.485
Fixed Eﬀects, Time dummies included, Clustered standard errors in parentheses, * p<0.10, ** p<0.05, *** p<0.01,
In accordance with the 'red herring' hypothesis, the coeﬃcients for most age
groups decrease once the mortality rate and its future values are included into
the model. However, the eﬀect of including these variables seems to be very
modest. Thus, our results give some evidence of the existence of a 'red herring',
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but age itself seems to have a strong impact on care costs even after controlling
for the mortality rates. The mortality rates are positive in all speciﬁcations2, the
future mortality rate and the aggregated one are found to be signiﬁcant at the
5 percent level. In economic terms, they are highly signiﬁcant: each additional
death is associated with cost increases of 21,500-63,300 SEK, depending on
speciﬁcation, suggesting that these variables are able to cover the end of life
morbidity impact on total care costs. Wald tests also do not reject the null
hypothesis of the equality of current and future mortality rates, suggesting that
they control for the same mechanism inﬂuencing care costs. Therefore, we regard
aggregation of both variables to be an appropriate way to control for the overall
eﬀect using just the aggregated variable  TTD65+.
A separate speciﬁcation for institutional and domiciliary LTC costs reveal
diﬀering cost for most age groups, suggesting ageing to be a more relevant pre-
dictor for domiciliary care, whereas morbidity seems to be more relevant for
institutional costs. The diﬀering signs of the coeﬃcients for TTD might be in-
terpreted as an indicator of age related switching behavior from domiciliary into
institutional care; economically this makes sense the two services are interpreted
as substitutes, which is a reasonable assumption.
Overall the estimated morbidity eﬀects in all scenarios are dwarfed by the
increase in expected costs at higher ages. Thus, our conclusion in this part
diﬀers signiﬁcantly from that of Larsson, Kåreholt and Thorslund (2008), who
ﬁnd that TTD is twice as important as age.
In order to check whether our estimates suﬀer from omitted variable bias,
we furthermore consider a speciﬁcation that takes into account other sociode-
mographic controls3. We have chosen the 65+ population's median income,
agglomeration (population density), gender (share of females in the 65+ po-
pulation), and the centre-right parties' share of all seats in the municipality.
We ﬁnd the coeﬃcients for the age cohorts being higher than in our baseline
model. The only new variable which is signiﬁcantly correlated with overall care
costs, is the median income of the elderly population. This positive correlation
is an interesting ﬁnding, since ﬁnancial wealth usually can be interpreted as
an indicator for a reduced health risk (Mackenbach, 2006). Our ﬁnding raises
the question if this reﬂects a higher LTC demand, or if we measure a positive
selection eﬀect of the wealthiest old into LTC services. Since we do not know
whether these covariates cause overall care costs, or if the changes are just due
to a partial correlation of age with the new variables, we later on prefer the
baseline speciﬁcation to discuss the implications of our estimates on the basis
of this more conservative approach.
4.2 Age Speciﬁc TTD Eﬀects
In addition to the above speciﬁcations, we now try to analyse the 'red herring'
hypothesis in more detail by testing whether the impact of TTD on care expen-
2Estimates in column 3 clearly overestimate the aggregate costs, since mrt is serielly cor-
related.
3Regression table is provided in the appendix A2.
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ditures is diﬀerent in diﬀerent age groups. If TTD eﬀects are age-speciﬁc, age
coeﬃcients might pick up TTD-related variation in care costs. Thus, it is im-
portant for a test of the 'red herring' hypothesis to allow for this possibility. We
therefore estimate our baseline model for overall, domiciliary and institutional
costs with age speciﬁc TTD-variables, i.e. instead of the single TTD measure
TTD65+ , we include a group speciﬁc TTD variable for every age cohort in our
model.
The results suggest that LTC costs diﬀer both between age groups and bet-
ween domiciliary and institutional care. Compared to our baseline model, the
inclusion of age speciﬁc TTD-variables increases the impact of age for the oldest
age group, whereas the coeﬃcient for the corresponding TTD variable becomes
negative. We suppose that this ﬁnding, which is mainly driven by institutional
costs, might be due to the fact that LTC services for the oldest old include less
expensive treatments compared to LTC for younger individuals. The estimated
coeﬃcients strongly suggest a heterogeneous impact of TTD between institu-
tional and domiciliary LTC costs. Again ageing seems to be most relevant for
domiciliary care. Interestingly, institutional LTC costs related to morbidity, can
to a large extent, be explained by a relatively young cohort, the 70 to 74 year
old people, for whom age is not a relevant determinant of LTC costs at all.
As in the estimate with the overall TTD variable included, diﬀering signs
of the TTD coeﬃcients suggest a switching behaviour from domiciliary to ins-
titutional LTC. The main ﬁnding is that population ageing is again the main
driving force of our care expenditure variables, even if we allow for age speciﬁc
TTD impacts.
4.3 Implications
To illustrate how our ﬁndings can be used for cost projections, we calculated the
expenditures arising due to an increase in life expectancy by one year for the
65+ population in 4 diﬀerent scenarios. We did this for total, institutional and
domicliary care costs on the basis of our estimators, combined with the Swedish
age structure and age speciﬁc mortality rates of the year 2008. This cost - life
expectancy relation4 can be described as
△LTCi =


∞∑
k=65
(
αj + βj
k
)
(sk−1 − sk) with j = i , for i = 1, 2
∞∑
k=65
((
αj + βj
k
)
(sk−1 − sk) + δ
j
k
(TTDk−1 − TTDk)
)
with j = i , for i = 3
αj=1 , for i = 4
We diﬀerentiate between a naive demographic extrapolation (i.e. TTD not
taken into account), 2 speciﬁcations where TTD variables are included into
the regression model, and a pure red herring scenario (i.e. all age-related costs
are costs of dying). △LTC is the change of care costs in each scenario i. α
4The formula for cost increase per year is provided in appendix A3.
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Table 3: Single TTD Variables
Total Inst Dom
age7074 -12.60 14.21 -21.23
(15.20) (17.24) (14.09)
age7579 6.76 -1.94 5.58
(15.92) (20.14) (16.05)
age8084 33.30* 18.32 20.42
(18.24) (20.18) (15.03)
age8589 132.72*** 59.05** 65.50***
(21.99) (23.71) (19.71)
age9094 224.84*** 60.18 163.71***
(35.22) (46.26) (34.37)
age95100 322.57*** 181.84 159.47*
(91.32) (115.53) (90.62)
TTD6569 71.14 62.66 -30.12
(47.15) (49.60) (43.97)
TTD7074 145.83*** 121.34*** 28.14
(41.19) (44.80) (39.55)
TTD7579 28.97 6.66 38.53
(35.02) (36.25) (29.88)
TTD8084 31.71 41.15 -8.83
(29.51) (37.07) (28.94)
TTD8589 -9.40 40.77 -46.40*
(30.71) (36.43) (27.70)
TTD9094 10.11 97.14** -88.11**
(40.30) (46.10) (41.55)
TTD95100+ -43.01 -35.33 -4.99
(90.01) (102.57) (83.57)
Constant 25.01*** 17.76* 4.81
(9.08) (10.60) (8.32)
Observations 3009 3009 3009
R2 0.597 0.277 0.487
Fixed Eﬀects, Time Dummies included, Clustered standard
errors in parentheses * p<0.10, ** p<0.05, *** p<0.01
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captures our model's constants, β represents our estimated age coeﬃcients (and
is therefore constant within 5-year intervals). s are survival rates and TTD TTD
variables calculated for individual age k = {65,..,100}. For j=1 we use results
from a regression where TTD is not controlled for, j=2 says that TTD65+ is
included and j=3 indicates the inclusion of TTDait into the regression model. The
TTD variables are just included into the formula for the speciﬁcation where age
speciﬁc TTD eﬀects are controlled for since they occur just once in a lifetime and
are therefore just inﬂuenced by a change in life expectancy if they are varying
with age. Results are presented in Figure 2. The upper panel shows the implied
change in lifetime care costs (from the current level of 947 kSEK in scenario 1 for
total care costs) and the lower panel shows the corresponding increase in average
costs per person per year (assuming a stationary population). Although our
results imply somewhat lower cost increases for total and institutional care costs
once TTD65+ is controlled for, the inclusion of the TTDa variables increases
the care costs for all 3 kinds of services which is driven by the relatively high
age coeﬃcients for the oldest old.
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Figure 1: Cost increases associated with a one-year increase in life expectancy
for various scenarios
4.4 IV Estimates
In Table 4 we compare the baseline FE estimate for overall care costs with the
use of our 2 instrumental variables5. To avoid the problem of more than one
endogenous explanatory variable we now just account for the single overall TTD
5First stages of 2SLS in Appendix A4
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measure.
Table 4: 2SLS
Total Total-IV1 Total-IV2 Total-IV1+2
age7074 -8.55 -14.32 -0.81 -11.30
(14.92) (16.51) (20.32) (15.50)
age7579 4.22 -7.56 20.04 -1.40
(15.23) (20.84) (35.04) (19.01)
age8084 30.24* 10.21 57.12 20.69
(17.77) (31.00) (56.51) (27.40)
age8589 120.03*** 86.17* 165.49* 103.88**
(20.15) (45.46) (96.40) (40.99)
age9094 209.35*** 149.17* 290.15* 180.65***
(29.52) (76.11) (166.88) (65.33)
age95100 270.00*** 205.26** 356.92* 239.13***
(59.93) (97.81) (188.00) (88.21)
TTD65+ 34.11** 156.95 -130.81 92.69
(14.03) (142.96) (345.46) (125.28)
Observations 3009 3009 3009 3009
R2 0.595 0.578 0.564 0.591
F-test 15.66 2.97 10.10
Hansen p-value 0.44
Fixed Eﬀects, Time dummies included, Clustered standard errors in
parentheses, * p<0.10, ** p<0.05, *** p<0.01
Due to the fact that we have 2 instrumental variables, we are able to provide
an overidentiﬁcation test6, which supports the validity of our IVs (p-value=0.44).
Using the IV controlling for marital status and network eﬀects on mortality (co-
lumn 2), we ﬁnd ageing to be less relevant than in the baseline model, but
economically still much more important for the prediction of LTC than TTD.
TTD we ﬁnd to be statistically insigniﬁcant, but economically much more im-
portant than in the baseline speciﬁcation, which seems to be reasonable if there
is a negative reverse causation from care services on mortality. The F-Statistic
suggests this IV to be strongly relevant.
Our 2nd instrumental variable (column 3) exposes to be signiﬁcant in the
ﬁrst stage of 2SLS, the results of this IV speciﬁcation should not be interpreted
to be causal because the F-statistic does not go beyond the critical value of 10.
We ﬁnd the TTD coeﬃcient to be negative but statistically insigniﬁcant. The
age coeﬃcients lose some signiﬁcance but their economic impact is even higher
6IV-estimates and test statistics are based on xtivreg2 (Schaﬀer, 2010).
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than in the pure Fixed-Eﬀects estimates.
Overall, our ﬁndings are twofold: First, there is some evidence for the 'red
herring' hypothesis since the impact of ageing loses some relevance, once TTD
is controlled for, in all our preferred speciﬁcations. Secondly, TTD itself is just
statistically signiﬁcant in the baseline speciﬁcation, suggesting that there is a
lot of variation in end of life morbidity. In addition, it seems that the age of
the older people still remains an important predictor of care costs - even if we
account for end of life morbidity.
5 Conclusion
In this paper, we analysed the eﬀect of ageing and increases in longevity on
care costs in Sweden. These relationships are of immense importance to policy
makers since they determine the need of future LTC, hence inﬂuencing care
costs due to demographic changes and shifts of life expectancy.
There are many missing pieces in this puzzle. The epidemiological literature
on the implications of increased longevity for morbidity and population health
remains inconclusive. Also, the related economic literature on the relationship
between ageing and health care costs has failed to deliver unambiguous results.
In an attempt to increase our knowledge on these issues, we used Swedish
administrative data to estimate an econometric model of the LTC determinants
in Swedish municipalities. By controlling for local mortality rates, we were able
to address the issue of whether TTD is a better predictor of care costs than
age. An advantage of our study is that the data used cover the entire Swedish
population. Therefore, our estimates can be assumed to be representative for
Sweden as a whole. Besides, since we have a panel dataset, our model allows
for unobserved heterogeneity. We used the Fixed Eﬀects estimator and also
considered IV estimation to achieve exogenous variation in TTD, and hence to
account for the potential problem of reverse causality. The main innovation of
our paper is that our measure for TTD allows us to control for the individual
end-of-life morbidity eﬀects on the aggregated level. Based on our ﬁndings in the
baseline speciﬁcation we calculated the ﬁnancial consequences of an increased
life expectancy by one year for various scenarios.
In addition to our baseline model, we considered several other speciﬁcati-
ons: Separate estimations for institutional and domiciliary LTC costs revealed
a morbidity related substitution into institutional care. In another speciﬁcation
we allowed for age speciﬁc TTD-eﬀects revealing the costs of end of life mor-
bidity itself to be strongly related to actual age at death. This issue is usually
not accounted for in the literature. In our study we ﬁnd the impact of TTD on
LTC costs to be mainly driven by a relatively young cohort, the 70 to 74 year
old persons.
The general message emerging from our analysis regarding changes of future
care costs is pessimistic. Even though care costs of the elderly are strongly
associated with local mortality rates  our estimates for this variable are not
very precise, but the economic signiﬁcance is considerable  the age structure
17
of a municipality remains a strong predictor of overall LTC costs even after we
account for mortality. Especially the number of the oldest old remains a relevant
predictor for LTC costs. Hence, it appears that as far as LTC in Sweden is
concerned, an 'expansion of morbidity' can be expected, meaning that unhealthy
years are added to life when life expectancy increases.
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Table A1: Summary statistics
Variable Mean Std. Dev. Min. Max. N
Total 57.376 9.002 23.464 94.41 3009
Inst 36.749 7.890 14.771 70.396 3009
Dom 18.146 5.619 3.598 43.024 3009
age6569 0.265 0.032 0.203 0.457 3009
age7074 0.233 0.015 0.19 0.281 3009
age7579 0.209 0.016 0.142 0.264 3009
age8084 0.159 0.017 0.084 0.21 3009
age8589 0.091 0.013 0.045 0.132 3009
age9094 0.035 0.007 0.014 0.06 3009
age95100 0.008 0.003 0.001 0.021 3009
mrt 0.051 0.007 0.031 0.089 3009
mrtL1 0.053 0.007 0.03 0.082 3009
TTD65+ 0.102 0.011 0.065 0.147 3009
TTD6569 0.007 0.002 0.001 0.018 3009
TTD7074 0.011 0.003 0.003 0.023 3009
TTD7579 0.017 0.004 0.005 0.034 3009
TTD8084 0.023 0.004 0.007 0.041 3009
TTD8589 0.024 0.004 0.006 0.041 3009
TTD9094 0.014 0.003 0.005 0.029 3009
TTD95100+ 0.005 0.002 -0.001 0.015 3009
TTD2554 0.003 0.001 0 0.008 3009
absmrtdiﬀ 0.019 0.011 0 0.116 3009
medinc65_08 153.652 19.414 94.625 240.874 3009
wom65 0.555 0.019 0.496 0.633 3009
density 126.722 416.08 0.2 4307.8 3009
rightwing 0.345 0.097 0.105 0.764 3009
22
Table A2: Robustness
Total Total
age7074 -8.55 -6.42
(14.99) (14.60)
age7579 4.22 8.37
(15.30) (15.72)
age8084 30.24* 43.80**
(17.85) (17.83)
age8589 120.03*** 141.85***
(20.24) (20.90)
age9094 209.35*** 230.27***
(29.66) (31.18)
age95100 270.00*** 302.39***
(60.21) (60.74)
TTD65+ 34.11** 32.09**
(14.10) (13.81)
medinc65_08 0.17***
(0.05)
wom65 3.93
(21.45)
density -0.00
(0.01)
rightwing -4.57
(5.00)
Constant 26.82*** -5.96
(9.00) (16.08)
Observations 3009 3009
R2 0.595 0.601
Fixed Eﬀects, Time dummies included,
Clustered standard errors in parentheses,
* p<0.10, ** p<0.05, *** p<0.01
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A3:Changes in cost increase per 65+ life year
△LTCi per Y ear =


∞∑
k=65
(
αj + βj
k
)

 sk−1∞∑
k=65
sk−1
−
sk
∞∑
k=65
sk

 with j = i , for i = 1, 2
∞∑
k=65


(
αj + βj
k
)

 sk−1∞∑
k=65
sk−1
−
sk
∞∑
k=65
sk

+ δjk

 TTDk−1∞∑
k=65
sk−1
−
TTDk
∞∑
k=65
sk



 with j = i , for i = 3
αj+
∞∑
k=65
(
αj+β
j
k
)
sk−1
∞∑
k=65
sk−1
−
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k=65
(
αj+β
j
k
)
sk
∞∑
k=65
sk
with j = 1 , for i = 4
Table A4: First Stage 2SLS
TTD65+ TTD65+ TTD65+
age7074 0.05** 0.05** 0.05**
(0.02) (0.02) (0.02)
age7579 0.10*** 0.10*** 0.10***
(0.02) (0.02) (0.02)
age8084 0.17*** 0.16*** 0.17***
(0.02) (0.02) (0.02)
age8589 0.28*** 0.28*** 0.28***
(0.03) (0.03) (0.03)
age9094 0.48*** 0.49*** 0.48***
(0.05) (0.05) (0.05)
age95100 0.52*** 0.52*** 0.52***
(0.10) (0.10) (0.10)
absmrtdiﬀ 0.04*** 0.04***
(0.01) (0.01)
TTD2554 0.31* 0.32*
(0.18) (0.18)
Observations 3009 3009 3009
R2 0.364 0.361 0.365
clustered standard errors in parentheses, time dummies
included, * p<0.10, ** p<0.05, *** p<0.01
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